Close Menu
    Subscribe
    Advertisement

    Events Search and Views Navigation

    Event Views Navigation

    Today

    65th Annual Biosafety and Biosecurity Conference

    Wisconsin Center 400 W. Wisconsin Ave., Milwaukee, WI, United States

    The ABSA's 65th Annual Biosafety and Biosecurity Conference will be held 14-19 October 2022 in a hybrid virtual and in-person format in Milwaukee, Wisconsin. The event offers intensive professional development courses over three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety and biosecurity professionals. Approximately

    GSRS22 – 12th Global Summit on Regulatory Science

    Orchard Hotel Singapore 442 Orchard Road, Singapore, Singapore

    GSRS22: The 12th Global Summit on Regulatory Science will be held from 19-21 October 2022 in Singapore. Convening under a theme of "Advances in Nanotechnology for Food and Medical Products: Innovations, Safety and Standards". the Summit will highlight topics including: Nanomaterials for Gene Delivery Nanotechnology in Agri-Products Emerging Nanomaterial Contaminants in Food Generic Medical Products

    CBRN Threats and Challenges – Fall Quarterly Update

    The NDIA will host a CBRN Threats and Challenges Fall Quarterly Update Forum on 19 October 2022. This quarterly meeting is set to provide a SECRET-level classified update from government representatives in the Chemical and Biological Defense Program (CBDP). This update will inform industry and government attendees about the CB Threat concerns that the DASD

    Board of Scientific Counselors, National Center for Health Statistics

    Virtual Event Virtual Event

    The CDC has announced the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) will convene 24 October 2022 in a live broadcast public meeting. The Board is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the

    In-Depth Look at Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs

    Virtual Event Virtual Event

    The FDA will host a meeting on 26 October 2022 to provide additional clarity to the final guidance with respect to Agency expectations for submissions containing Bioavailability information for drug products, and will discuss: Select case studies on various bioavailability (BA) related subtopics (e.g. pharmacodynamic (PD) endpoints, endogenous compound Narrow Therapeutic Index (NTI), biowaivers). Bioavailability

    Responding to the Climate Change and Health Crisis: A Framework for Academic Public Health

    Virtual Event Virtual Event

    The Association of Schools and Programs of Public Health (ASPPH) will host a framework launch webinar on Responding to the Climate Change and Health Crisis from 2:00 – 3:00 PM ET on Wednesday, October 26, featuring an expert panel that will discuss some of the challenges and opportunities it identifies. The framework examines climate change

    Best Practices: Modeling Approaches to Support Generic Product Development

    Virtual Event Virtual Event

    FDA and the Center for Research on Complex Generics (CRCG) will host a free public workshop on October 27-28, 2022: Best Practices for Utilizing Modeling Approaches to Support Generic Product Development The purpose of this two-day workshop is to discuss and illustrate how generic product developers can utilize modeling approaches in conjunction with in vitro

    Public Health Workforce Calculator: Staffing up to Achieve Foundational Services

    Virtual Event Virtual Event

    In 2021, an analysis of the public health workforce found that state and local governmental public health departments need an 80% increase in their workforce to provide a minimum set of public health services to the nation. In response to this gap, the Public Health National Center for Innovations at PHAB, de Beaumont Foundation, and

    Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting

    Virtual Event Virtual Event

    On November 2, 2022, the committee will discuss the Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) program. QMM is the state attained when drug manufacturers have consistent, reliable, and robust business processes to achieve quality objectives and promote continual improvement. CDER has proposed the development of a rating system that will